벼룩, 진드기, 심장사상충 제품 시장 : 규모, 점유율, 동향 분석, 제품별, 유형별, 동물별, 투여 방법별, 기생충별, 케어별, 유통 채널별, 지역별, 부문(2025-2033년)

Flea, Tick And Heartworm Products Market Summary

The global flea, tick and heartworm products market size was estimated at USD 7.85 billion in 2024 and is projected to reach USD 15.21 billion by 2033, growing at a CAGR of 7.62% from 2025 to 2033. The market is experiencing growth driven by the increasing prevalence of vector-borne diseases, the growing importance of preventive care, and the emergence of novel FTH products.

A rise in the spread of heartworm disease and cases of parasitic infestations among animals is also expected to fuel the growth of the flea, tick and heartworm products industry. The expansion of flea-, tick-, and mosquito-borne diseases like Lyme disease, ehrlichiosis, and heartworm is creating greater awareness among pet owners and veterinarians about preventive care. In recent years, their spread has been on the rise globally. According to 2023 data published by the American Veterinary Medical Association (AVMA) and the American Heartworm Society (AHS), estimated that in 2022, many veterinary clinics in the U.S. handled over 100+ cases of heartworm disease in animals per clinic. Of the total veterinarians who responded to this survey, 29% reported that heartworm disease cases have steadily risen over the last year. The prevalence of heartworm diseases was reported to be about 20% for dogs and 33% for cats in the U.S., according to a March 2024 study published in the Parasites & Vectors journal.

In addition, a March 2024 release by the British Small Animal Veterinary Association (BSAVA) reported that even though the disease is not endemic in the UK, heartworm disease diagnosis has been steadily increasing, with most cases found in dogs. Additionally, a study was conducted in Australia to understand the prevalence of heartworm infection in dogs. This February 2023 study inferred that the prevalence was estimated to be as high as 32.1%, varying slightly in different areas of the country.

The market is set to experience high growth prospects in the forecast period. One of the crucial drivers in this market is the increasing emphasis put by veterinary professionals on the importance of preventive care in animals for managing parasitic infections like flea, tick, and heartworm. Preventive care focuses on administering FTH medication to animals like cats & dogs since their early years of development, irrespective of infestation. Product manufacturers are also actively innovating and seeking regulatory approvals to increase their product portfolio and assist in effectively managing these conditions.

Furthermore, a Merck Animal Health survey of August 2025 revealed a significant gap between pet owners' intentions and their actual compliance with flea and tick prevention. Most owners recognize the importance of treatment, struggle with timely administration, seasonal misconceptions, and lack of awareness about vector-borne diseases like ehrlichiosis. This highlights an urgent need for education and long-duration solutions. These compliance challenges are driving demand for innovative, long-lasting, and veterinarian-prescribed flea and tick preventives. As awareness grows, companies offering annual or extended-duration treatments are likely to see strong adoption and revenue growth.

Global Flea, Tick and Heartworm Products Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global flea, tick and heartworm products market report based on product, type, animal, mode of delivery, parasite, care, distribution channel, and region:

• Product Outlook (Revenue, USD Million, 2021 - 2033)
• Diagnostic Products
  • Test Kits
  • Consumables
• Treatment Products
  • Spot on
  • Oral pills/Chewable
  • Spray
  • Liquid Solution
  • Shampoo
  • Others
• Type Outlook (Revenue, USD Million, 2021 - 2033)
• Prescription
• OTC
• Animal Outlook (Revenue, USD Million, 2021 - 2033)
• Canine
• Feline
• Others
• Mode of Delivery Outlook (Revenue, USD Million, 2021 - 2033)
• Topical
• Oral
• Injectable
• Parasite Outlook (Revenue, USD Million, 2021 - 2033)
• External Parasite
• Internal Parasite
• Care Outlook (Revenue, USD Million, 2021 - 2033)
• Preventive Care
• Therapeutic Care
• Distribution Channel Outlook (Revenue, USD Million, 2021 - 2033)
• Hospital/Clinic Pharmacy
• Retail Pharmacy
• Online Pharmacy
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • Thailand
  • South Korea
• Latin America
  • Brazil
  • Argentina
• Middle East & Africa
  • South Africa
  • UAE
  • Saudi Arabia
  • Kuwait
  • Qatar
  • Oman

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Segment Definitions
  • 1.2.1. Product
  • 1.2.2. Type
  • 1.2.3. Animal
  • 1.2.4. Mode of Delivery
  • 1.2.5. Parasite
  • 1.2.6. Care
  • 1.2.7. Distribution Channel
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased Database
  • 1.4.2. GVR's Internal Database
  • 1.4.3. Secondary Sources
  • 1.4.4. Primary Research
• 1.5. Information/Data Analysis
  • 1.5.1. Data Analysis Models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Model 1 Analysis
  • 1.7.2. Model 2 Analysis
  • 1.7.3. Model 3 Analysis
• 1.8. List of Secondary Sources
• 1.9. List Of Abbreviations
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. Market Variable Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Ancillary/Related Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Increasing Prevalence Of Vector-Borne Diseases
    • 3.2.1.2. Growing Importance Of Preventive Care
    • 3.2.1.3. Emergence Of Novel FTH Products
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. High Costs Of Flea, Tick, And Heartworm Products
• 3.3. Market Opportunity Analysis
• 3.4. Market Challenge Analysis
• 3.5. Technology Landscape
• 3.6. Pricing Model Analysis
• 3.7. Estimated Animal Population By Species, By Region, 2024
• 3.8. Market Analysis Tools
  • 3.8.1. Porter's Five Forces Analysis
  • 3.8.2. PESTEL by SWOT Analysis

Chapter 4. Flea, Tick And Heartworm Products Market: Product Estimates & Trend Analysis

• 4.1. Flea, Tick And Heartworm Products Market, By Product: Segment Dashboard
• 4.2. Flea, Tick And Heartworm Products Market, By Product Movement Analysis
• 4.3. Flea, Tick And Heartworm Products Market Estimates & Forecasts, by Product, 2021 to 2033 (USD Million)
• 4.4. Diagnostic Products
  • 4.4.1. Diagnostic Products Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4.2. Test Kits
    • 4.4.2.1. Test Kits Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4.3. Consumables
    • 4.4.3.1. Consumables Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.5. Treatment Products
  • 4.5.1. Treatment Products Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5.2. Spot on
    • 4.5.2.1. Spot on Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5.3. Oral pills/Chewable
    • 4.5.3.1. Oral pills/Chewable Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5.4. Spray
    • 4.5.4.1. Spray Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5.5. Liquid Solution
    • 4.5.5.1. Liquid Solution Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5.6. Shampoo
    • 4.5.6.1. Shampoo Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5.7. Others
    • 4.5.7.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Flea, Tick And Heartworm Products Market: Type Estimates & Trend Analysis

• 5.1. Flea, Tick And Heartworm Products Market, By Type: Segment Dashboard
• 5.2. Flea, Tick And Heartworm Products Market, By Type Movement Analysis
• 5.3. Flea, Tick And Heartworm Products Market Estimates & Forecasts, by Type, 2021 to 2033 (USD Million)
• 5.4. Prescription
  • 5.4.1. Prescription Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.5. OTC
  • 5.5.1. OTC Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Flea, Tick And Heartworm Products Market: By Animal Estimates & Trend Analysis

• 6.1. Flea, Tick And Heartworm Products Market, By Animal: Segment Dashboard
• 6.2. Flea, Tick And Heartworm Products Market, By Animal Movement Analysis
• 6.3. Flea, Tick And Heartworm Products Market Estimates & Forecasts, by Animal, 2021 to 2033 (USD Million)
• 6.4. Canine
  • 6.4.1. Canine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.5. Feline
  • 6.5.1. Feline Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.6. Others
  • 6.6.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Flea, Tick And Heartworm Products Market: By Mode of Delivery Estimates & Trend Analysis

• 7.1. Flea, Tick And Heartworm Products Market, By Mode of Delivery: Segment Dashboard
• 7.2. Flea, Tick And Heartworm Products Market, By Mode of Delivery Movement Analysis
• 7.3. Flea, Tick And Heartworm Products Market Estimates & Forecasts, by Mode of Delivery 2021 to 2033 (USD Million)
• 7.4. Topical
  • 7.4.1. Topical Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.5. Oral
  • 7.5.1. Oral Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.6. Injectable
  • 7.6.1. Injectable Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Flea, Tick And Heartworm Products Market: By Parasite Estimates & Trend Analysis

• 8.1. Flea, Tick And Heartworm Products Market, By Parasite: Segment Dashboard
• 8.2. Flea, Tick And Heartworm Products Market, By Parasite Movement Analysis
• 8.3. Flea, Tick And Heartworm Products Market Estimates & Forecasts, by Parasite, 2021 to 2033 (USD Million)
• 8.4. External Parasite
  • 8.4.1. External Parasite Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 8.5. Internal Parasite
  • 8.5.1. Internal Parasite Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 9. Flea, Tick And Heartworm Products Market: By Care Estimates & Trend Analysis

• 9.1. Flea, Tick And Heartworm Products Market, By Care: Segment Dashboard
• 9.2. Flea, Tick And Heartworm Products Market, By Care Movement Analysis
• 9.3. Flea, Tick And Heartworm Products Market Estimates & Forecasts, by Care, 2021 to 2033 (USD Million)
• 9.4. Preventive Care
  • 9.4.1. Preventive Care Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 9.5. Therapeutic Care
  • 9.5.1. Therapeutic Care Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 10. Flea, Tick And Heartworm Products Market: By Distribution Channel Estimates & Trend Analysis

• 10.1. Flea, Tick And Heartworm Products Market, By Distribution Channel: Segment Dashboard
• 10.2. Flea, Tick And Heartworm Products Market, By Distribution Channel Movement Analysis
• 10.3. Flea, Tick And Heartworm Products Market Estimates & Forecasts, by Distribution Channel, 2021 to 2033 (USD Million)
• 10.4. Hospital/Clinic Pharmacy
  • 10.4.1. Hospital/Clinic Pharmacy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 10.5. Retail Pharmacy
  • 10.5.1. Retail Pharmacy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 10.6. Online Pharmacy
  • 10.6.1. Online Pharmacy Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 11. Flea, Tick And Heartworm Products Market: By Regional Estimates & Trend Analysis

• 11.1. Region Market Dashboard
• 11.2. Region Market Share Analysis, 2024 & 2033
• 11.3. North America
  • 11.3.1. North America Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 11.3.2. U.S
    • 11.3.2.1. Key Country Dynamics
    • 11.3.2.2. Competitive Scenario
    • 11.3.2.3. Regulatory Framework
    • 11.3.2.4. U.S. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 11.3.3. Canada
    • 11.3.3.1. Key Country Dynamics
    • 11.3.3.2. Competitive Scenario
    • 11.3.3.3. Regulatory Framework
    • 11.3.3.4. Canada Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 11.3.4. Mexico
    • 11.3.4.1. Key Country Dynamics
    • 11.3.4.2. Competitive Scenario
    • 11.3.4.3. Regulatory Framework
    • 11.3.4.4. Mexico Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 11.4. Europe
  • 11.4.1. Europe Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 11.4.2. UK
    • 11.4.2.1. Key Country Dynamics
    • 11.4.2.2. Competitive Scenario
    • 11.4.2.3. Regulatory Framework
    • 11.4.2.4. UK Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 11.4.3. Germany
    • 11.4.3.1. Key Country Dynamics
    • 11.4.3.2. Competitive Scenario
    • 11.4.3.3. Regulatory Framework
    • 11.4.3.4. Germany Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 11.4.4. France
    • 11.4.4.1. Key Country Dynamics
    • 11.4.4.2. Competitive Scenario
    • 11.4.4.3. Regulatory Framework
    • 11.4.4.4. France Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 11.4.5. Italy
    • 11.4.5.1. Key Country Dynamics
    • 11.4.5.2. Competitive Scenario
    • 11.4.5.3. Regulatory Framework
    • 11.4.5.4. Italy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 11.4.6. Spain
    • 11.4.6.1. Key Country Dynamics
    • 11.4.6.2. Competitive Scenario
    • 11.4.6.3. Regulatory Framework
    • 11.4.6.4. Spain Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 11.4.7. Denmark
    • 11.4.7.1. Key Country Dynamics
    • 11.4.7.2. Competitive Scenario
    • 11.4.7.3. Regulatory Framework
    • 11.4.7.4. Denmark Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 11.4.8. Sweden
    • 11.4.8.1. Key Country Dynamics
    • 11.4.8.2. Competitive Scenario
    • 11.4.8.3. Regulatory Framework
    • 11.4.8.4. Sweden Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 11.4.9. Norway
    • 11.4.9.1. Key Country Dynamics
    • 11.4.9.2. Competitive Scenario
    • 11.4.9.3. Regulatory Framework
    • 11.4.9.4. Norway Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 11.5. Asia Pacific
  • 11.5.1. Asia Pacific Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 11.5.2. Japan
    • 11.5.2.1. Key Country Dynamics
    • 11.5.2.2. Competitive Scenario
    • 11.5.2.3. Regulatory Framework
    • 11.5.2.4. Japan Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 11.5.3. China
    • 11.5.3.1. Key Country Dynamics
    • 11.5.3.2. Competitive Scenario
    • 11.5.3.3. Regulatory Framework
    • 11.5.3.4. China Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 11.5.4. India
    • 11.5.4.1. Key Country Dynamics
    • 11.5.4.2. Competitive Scenario
    • 11.5.4.3. Regulatory Framework
    • 11.5.4.4. India Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 11.5.5. Australia
    • 11.5.5.1. Key Country Dynamics
    • 11.5.5.2. Competitive Scenario
    • 11.5.5.3. Regulatory Framework
    • 11.5.5.4. Australia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 11.5.6. Thailand
    • 11.5.6.1. Key Country Dynamics
    • 11.5.6.2. Competitive Scenario
    • 11.5.6.3. Regulatory Framework
    • 11.5.6.4. Thailand Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 11.5.7. South Korea
    • 11.5.7.1. Key Country Dynamics
    • 11.5.7.2. Competitive Scenario
    • 11.5.7.3. Regulatory Framework
    • 11.5.7.4. South Korea Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 11.6. Latin America
  • 11.6.1. Latin America Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 11.6.2. Brazil
    • 11.6.2.1. Key Country Dynamics
    • 11.6.2.2. Competitive Scenario
    • 11.6.2.3. Regulatory Framework
    • 11.6.2.4. Brazil Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 11.6.3. Argentina
    • 11.6.3.1. Key Country Dynamics
    • 11.6.3.2. Competitive Scenario
    • 11.6.3.3. Regulatory Framework
    • 11.6.3.4. Argentina Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 11.7. MEA
  • 11.7.1. MEA Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 11.7.2. South Africa
    • 11.7.2.1. Key Country Dynamics
    • 11.7.2.2. Competitive Scenario
    • 11.7.2.3. Regulatory Framework
    • 11.7.2.4. South Africa Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 11.7.3. UAE
    • 11.7.3.1. Key Country Dynamics
    • 11.7.3.2. Competitive Scenario
    • 11.7.3.3. Regulatory Framework
    • 11.7.3.4. UAE Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 11.7.4. Saudi Arabia
    • 11.7.4.1. Key Country Dynamics
    • 11.7.4.2. Competitive Scenario
    • 11.7.4.3. Regulatory Framework
    • 11.7.4.4. Saudi Arabia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 11.7.5. Kuwait
    • 11.7.5.1. Key Country Dynamics
    • 11.7.5.2. Competitive Scenario
    • 11.7.5.3. Regulatory Framework
    • 11.7.5.4. Kuwait Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 11.7.6. Qatar
    • 11.7.6.1. Key Country Dynamics
    • 11.7.6.2. Competitive Scenario
    • 11.7.6.3. Regulatory Framework
    • 11.7.6.4. Qatar Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 11.7.7. Oman
    • 11.7.7.1. Key Country Dynamics
    • 11.7.7.2. Competitive Scenario
    • 11.7.7.3. Regulatory Framework
    • 11.7.7.4. Oman Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 12. Competitive Landscape

• 12.1. Market Participant Categorization
  • 12.1.1. Market Leaders
  • 12.1.2. Emerging Players
• 12.2. Market Share/Assessment Analysis, 2024 (Heat Map Analysis)
• 12.3. Company Profiles
  • 12.3.1. Zoetis Services LLC
    • 12.3.1.1. Participant's Overview
    • 12.3.1.2. Financial Performance
    • 12.3.1.3. Product/Service Benchmarking
    • 12.3.1.4. Strategic Initiatives
  • 12.3.2. Boehringer Ingelheim International GmbH
    • 12.3.2.1. Participant's Overview
    • 12.3.2.2. Financial Performance
    • 12.3.2.3. Product/Service Benchmarking
    • 12.3.2.4. Strategic Initiatives
  • 12.3.3. Merck & Co., Inc.
    • 12.3.3.1. Participant's Overview
    • 12.3.3.2. Financial Performance
    • 12.3.3.3. Product/Service Benchmarking
    • 12.3.3.4. Strategic Initiatives
  • 12.3.4. Virbac
    • 12.3.4.1. Participant's Overview
    • 12.3.4.2. Financial Performance
    • 12.3.4.3. Product/Service Benchmarking
    • 12.3.4.4. Strategic Initiatives
  • 12.3.5. Elanco
    • 12.3.5.1. Participant's Overview
    • 12.3.5.2. Financial Performance
    • 12.3.5.3. Product/Service Benchmarking
    • 12.3.5.4. Strategic Initiatives
  • 12.3.6. Ceva
    • 12.3.6.1. Participant's Overview
    • 12.3.6.2. Financial Performance
    • 12.3.6.3. Product/Service Benchmarking
    • 12.3.6.4. Strategic Initiatives
  • 12.3.7. Promika, LLC
    • 12.3.7.1. Participant's Overview
    • 12.3.7.2. Financial Performance
    • 12.3.7.3. Product/Service Benchmarking
    • 12.3.7.4. Strategic Initiatives
  • 12.3.8. Sergeant's Pet Care Products, Inc.
    • 12.3.8.1. Participant's Overview
    • 12.3.8.2. Financial Performance
    • 12.3.8.3. Product/Service Benchmarking
    • 12.3.8.4. Strategic Initiatives
  • 12.3.9. ADAMS (Central Garden & Pet)
    • 12.3.9.1. Participant's Overview
    • 12.3.9.2. Financial Performance
    • 12.3.9.3. Product/Service Benchmarking
    • 12.3.9.4. Strategic Initiatives
  • 12.3.10. Bionote USA In
    • 12.3.10.1. Participant's Overview
    • 12.3.10.2. Financial Performance
    • 12.3.10.3. Product/Service Benchmarking
    • 12.3.10.4. Strategic Initiatives
  • 12.3.11. Secure Diagnostics Pvt. Ltd.
    • 12.3.11.1. Participant's Overview
    • 12.3.11.2. Financial Performance
    • 12.3.11.3. Product/Service Benchmarking
    • 12.3.11.4. Strategic Initiatives
  • 12.3.12. iNtRON Biotechnology
    • 12.3.12.1. Participant's Overview
    • 12.3.12.2. Financial Performance
    • 12.3.12.3. Product/Service Benchmarking
    • 12.3.12.4. Strategic Initiatives
  • 12.3.13. Biopanda Reagents Ltd.
    • 12.3.13.1. Participant's Overview
    • 12.3.13.2. Financial Performance
    • 12.3.13.3. Product/Service Benchmarking
    • 12.3.13.4. Strategic Initiatives
• 12.4. List of other key players